Clinical Trial Update: Evaluating the Effects of Adjunctive Aripiprazole on Weight and Metabolic Outcomes in Females [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating adjunctive aripiprazole for weight and metabolic outcomes in women with psychosis and metabolic syndrome. The study is not cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome
• Psychosis

Drugs mentioned

• Abilify (aripiprazole)

Snippet

Sponsor: Universiti Putra Malaysia | Conditions: Psychosis, Metabolic Syndrome | Phase 4 | Status: NOT_YET_RECRUITING